No Result

View All Result

No products in the cart.

2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑

Home StudyGraphics

#VisualAbstract: Resmetirom improves outcomes in patients with nonalcoholic steatohepatitis (NASH) compared to placebo

byMinjee Kim

February 9, 2024

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Resmetirom improves outcomes in patients with nonalcoholic steatohepatitis (NASH) compared to placebo

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Sodium-glucose cotransporter 2 inhibitors may decrease risk of serious liver events in patients with cirrhosis

Durvalumab and bevacizumab plus chemoembolization improves progression-free survival in hepatocellular carcinoma

Characterization of the increased incidence of alcohol-associated hepatitis noted in Ontario, Canada in past two decades

Adults over the age of sixty-five spend over twenty days per year obtaining health care

RelatedReports

Low free sugar diet reduces hepatic steatosis in nonalcoholic fatty liver disease in adolescent males

Chronic Disease

Sodium-glucose cotransporter 2 inhibitors may decrease risk of serious liver events in patients with cirrhosis

July 2, 2025

Prognostic indicators for transarterial chemoembolization in patients with hepatocellular carcinoma with extrahepatic spread identified

Chronic Disease

Durvalumab and bevacizumab plus chemoembolization improves progression-free survival in hepatocellular carcinoma

March 13, 2025

Increasing survival rates for patients with acute liver failure

Chronic Disease

Characterization of the increased incidence of alcohol-associated hepatitis noted in Ontario, Canada in past two decades

February 11, 2025

Chronic Disease

High levels of serum hypersensitive C-reactive protein are associated with non-alcoholic fatty liver

December 3, 2024

Steroids and opioids often inappropriately prescribed in the emergency department for pediatric pneumonia and sinusitis

Ketamine may be non-inferior to morphine for out-of-hospital traumatic pain management

Increased number of daily steps linked with decreased mortality in older women

Smartphone-based shopping mall walking programs increased daily step counts of users during the pandemic

Quick Take: Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study

First-line rituximab for pemphigus associated with long-term complete remission rates

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Resmetirom improves outcomes in patients with nonalcoholic steatohepatitis (NASH) compared to placebo

Sodium-glucose cotransporter 2 inhibitors may decrease risk of serious liver events in patients with cirrhosis

Durvalumab and bevacizumab plus chemoembolization improves progression-free survival in hepatocellular carcinoma

Characterization of the increased incidence of alcohol-associated hepatitis noted in Ontario, Canada in past two decades

Adults over the age of sixty-five spend over twenty days per year obtaining health care

Ketamine may be non-inferior to morphine for out-of-hospital traumatic pain management

RelatedReports

Sodium-glucose cotransporter 2 inhibitors may decrease risk of serious liver events in patients with cirrhosis

Durvalumab and bevacizumab plus chemoembolization improves progression-free survival in hepatocellular carcinoma

Characterization of the increased incidence of alcohol-associated hepatitis noted in Ontario, Canada in past two decades

High levels of serum hypersensitive C-reactive protein are associated with non-alcoholic fatty liver

Ketamine may be non-inferior to morphine for out-of-hospital traumatic pain management

Smartphone-based shopping mall walking programs increased daily step counts of users during the pandemic

First-line rituximab for pemphigus associated with long-term complete remission rates

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits